publication venue for
- The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes.. 27:-. 2025
- Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference.. 27:-. 2025
- Correction to: Built Environment and Cardiovascular Diseases - Insights from a Global Review.. 27:-. 2025
- Built Environment and Cardiovascular Diseases - Insights from a Global Review.. 27:-. 2025
- Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions.. 27:-. 2025
- Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 European Society of Cardiology Congress.. 27:-. 2024
- Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference.. 26:367-381. 2024
- Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress.. 25:965-978. 2023
- The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations.. 25:351-357. 2023
- Management of Ischemic Heart Disease in Pregnancy.. 23:-. 2021
- The Link Between Obstructive Sleep Apnea and Cardiovascular Disease.. 18:-. 2016
- CD39: Interface between vascular thrombosis and inflammation.. 16:-. 2014
- Cardiometabolic impact of non-statin lipid lowering therapies.. 16:-. 2014
- Therapeutic hypothermia after cardiac arrest.. 12:336-42. 2010